SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950142-21-003505
Filing Date
2021-11-02
Accepted
2021-11-02 16:06:27
Documents
1
Period of Report
2021-07-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT es210197024_4-javittd.html 4  
1 OWNERSHIP DOCUMENT es210197024_4-javittd.xml 4 5484
  Complete submission text file 0000950142-21-003505.txt   7002
Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1201 NORTH MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address
Javitt Daniel C. (Reporting) CIK: 0001864534 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38302 | Film No.: 211371252